A 31-year-old woman had ureterolithiasis related to hypercalcemia, and when she was admitted to our hospital ultrasonography and technetium-99 m sestamibi scintigraphy did not detect parathyroid abnormalities. Serum concentrations of calcium and intact parathyroid hormone were 9.7 mg/dl and 153 pg/ml, respectively, but subsequently increased to 13.5 mg/dl and decreased to 10 pg/ml, respectively. Diagnostic interview revealed that she had been taking excessive calcium supplements of 3,000~5,000 mg/day because she was worried about developing osteoporosis. Her hypercalcemia was cured after she stopped taking the supplements. The present case indicates that calcium supplementation of more than 2,500 mg/day elicits adverse effects on body mineral balance. Clear indications of the upper limits to supplements should be made known to the consumers.
CALCIUM (Ca) intake is necessary for accumulating peak bone mass in the young and for preventing decrease of bone mineral density in the old. Recommended dietary allowance of Ca is proposed to be more than 600 mg/day for the general population [1] and more than 800 mg/day for osteoporosis therapy in our country [2] . Currently, the average Ca intake among the Japanese is insufficient (~550 mg/day) [3] . Ca supplement is a convenient method to compensate for the insufficient Ca intake from daily diet. Several kinds of supplements have come onto the market and are common nowadays. The usual recommended dose of Ca rarely causes hypercalcemia [4] . However, excessive intake of Ca supplement can lead to adverse health effects and can cause hypercalcemia [5] . For such reasons, the tolerable upper limit of Ca supplement was established at 2,500 mg/day in the United States and Canada in 1997 [6] , which was only a half of the level observed to present an adverse effect (5,000 mg/day) [7] . In view of these recommendations, the same standard was also established in Japan in 2000 [1, 5] .
Despite the establishment of such standards, we encountered a patient who showed hypercalcemia that was induced by excessive intake of Ca supplements. As the clinical findings resembled primary hyperparathyroidism (PHPT) and familial hypocalciuric hypercalcemia (FHH), the differential diagnosis was difficult. We report and describe the mechanism of a typical case of how Ca overdose can cause adverse health effects by disturbing the mineral balance in the body.
Case report
A 31-year-old Japanese woman was admitted to Tokyo Women's Medical University Hospital on April 11, 2002 . She was found with hypercalcemia at Matsudo City Hospital in September 2001, when she suffered from pyelonephritis caused by ureterolithiasis. Her serum levels of Ca, P and intact parathyroid hormone (intact-PTH) were 11.4 mg/dl, 6.3 mg/dl, and 100 pg/ml, respectively. A 5 mm nodule was detected near the thyroid gland by magnetic resonance imaging (MRI).
She was referred to the Department of Surgical Endocrinology at our hospital in January 2002. Her serum concentrations of Ca and intact-PTH were 9.7 mg/dl and 153 pg/ml, respectively. But ultrasonography (US) of the neck did not detect parathyroid. After she was referred to our department, serum Ca rose to 13.5 mg/ dl and intact-PTH decreased to 10 pg/ml in March 2002, and the levels were 10.5 mg/dl and 47 pg/ml, respectively in April 2002 (Table 1) .
On admission, she was 159.5 cm in height and was 44.5 kg in weight. Symptoms accompanying hyper- Table 2 . Both serum Ca and intact-PTH were slightly elevated to 11.7 mg/dl (normal range: 8.5-10.0) and 81 pg/ml (normal range: 10-65), respectively, while serum inorganic phosphate (P) was also elevated to 4.9 mg/dl (normal range: 2.5-4.3). Computed tomography (CT) of the abdomen revealed calcifications in the bilateral renal medulla and a tiny stone was found in the left kidney. Bone mineral density of her lumbar spine was normal. To confirm the absence of PHPT, US of the neck was performed again, but no abnormalities of the parathyroid gland were detected. Technetium-99 m sestamibi scintigraphy also revealed no abnormal finding. On urinalysis, Ca to creatinine clearance ratio (Cca/ Ccr) was extremely low (0.0045), a level compatible with FHH [8] . The patient had no hypercalcemic relatives. The serum Ca of her father and mother were 9.5 mg/dl and 9.3 mg/dl, respectively. After obtaining informed consent, we performed gene analysis of her calcium-sensing receptor (CaSR) and the result revealed no mutation [9, 10] . Her PTH-related peptide (PTHrP) had slightly elevated to 1.7 pmol/l (normal range: <1.1) in April 2002, but it decreased to normal range (0.2 pmol/l) on admission. Abdominal CT, upper gastrointestinal endoscope and gynecological screenings revealed no abnormal finding.
The patient's endocrinological data showed extremely high levels of plasma renin activity (PRA) (25 ng/ml/h; normal range: 0.5-3.0) and plasma aldosterone concentration (PAC) (36.0 ng/dl; normal range: 2.2-15.0). Her blood urea nitrogen (9.1 mg/dl) and creatinine (0.93 mg/dl) were normal and creatinine clearance was 94.2 ml/minute. Diagnostic interview revealed that she had been overusing diuretics (Chinese herbal medicine, spironolactone), because she was obsessed with the idea that her legs were edematous although clinical diagnosis showed no distinct edema. Furthermore, she abusively used purgatives (magnesium oxide, sennoside, Alosenn R ) because she suffered from a severe proctocele and had constipation. As she had been told of having hypokalemia from taking potassium, her serum potassium was normal (4.0 mEq/l) on admission. We diagnosed that hypovolemia from excessive diuretics and purgatives had caused high levels of PRA and secondary aldosteronism. After she reduced dosage of these drugs during admission, her PRA and PAC gradually became normal (5.4 ng/ml/h and 20.0 ng/dl, respectively). More detailed interview revealed that she had been taking excessive calcium supplement, iron supplement and multivitamins for many years. She was worried about developing osteoporosis because many of her relatives suffered from the disease. She had been taking at least 30 tablets of Ca supplement and sometimes to a maximum of 50 tablets per day. Each tablet contained 100 mg of Ca and 69 mg of P. The Ca supplement contained mostly calcium phosphate that was derived from bovine bones, prepared in Japan. Total vitamin D from the Ca supplement as well as from the multivitamin supplements was about 2,000 IU/day. But her serum 1,25-(OH) 2 D level was normal (31.6 pg/ml; normal range: 20-60). Three weeks after admission, during which Ca supplements were withdrawn, her serum Ca and P decreased to 8.8 mg/dl and 4.2 mg/dl, respectively. To reconfirm the effects of Ca supplements on serum electrolytes, we asked her to take 30 tablets per day of Ca supplements for 5 days at home. After she returned to our hospital, serum Ca, P and intact-PTH increased to 10.1 mg/dl, 3.9 mg/dl and 77 pg/ml, respectively.
After an operation on her severe proctocele in October 2002, she had no more constipation and thus discontinued purgatives and all other supplements. In July 2003, her urinary Ca excretion was normal (110 mg/ day) and her serum level of Ca remained in the normal range (9.7 mg/dl) (Fig. 1) .
Discussion
We described a patient with hypercalcemia induced by extremely excessive intake of Ca supplements. The case indicates that excessive Ca intake of more than 2,500 mg per day is harmful to health.
Ca at doses generally recommended for osteoporosis does not cause hypercalcemia. A study showed that daily Ca administration of 1,600 mg to 88 elderly women for 4 years found only one subject with mild hypercalcemia [4] . Significant unbalanced intake of some nutrient can lead to adverse health effects [11] . A report found eight hypercalcemic cases among cancer patients studied and deduced that nutritional supplements might have contributed to their hypercalcemia [12, 13] . The lowest observed adverse level of Ca intake was 5,000 mg/day [7] and the tolerable upper limit of Ca was set at 2,500 mg/day in the United States and Canada in 1997 [6] . Recently, various nutritional supplements including nutritional elements, functional foods and health foods are popular and are widely available in Japan. Therefore, the tolerable upper limit of calcium was also set in Japan in 2000 [1, 5] . Despite the advice on dosage, the present patient had been taking Ca of more than 3,000 mg/day for a prolonged period, which finally led to hypercalcemia. On first diagnosis, the patient was suspected of PHPT because MRI detected a 5 mm nodule near the thyroid gland. And she had ureterolithiasis (possibly caused by excessive excretion of Ca into the urine). Her serum levels of Ca were not stable (Table 1) . Her data of suppressed intact-PTH (10 pg/ml) in the presence of high serum Ca levels (13.5 mg/dl) and P levels (6.4 mg/dl) on March 14 ruled out the PHPT diagnosis. Further examinations by US on the neck and by technetium-99 m sestamibi scintigraphy revealed no abnormal finding. Relationships between serum Ca and intact-PTH of 82 patients with PHPT, who were admitted to our Department of Medicine from 1993 to 2000, are represented in Fig. 2 . Data of the present patient were distinctly different from the PHPT patients, which again tell us that the present patient did not have PHPT. It should be pointed out that serum levels of Ca and intact-PTH sometimes increased simultaneously in the present patient. The reason may be explained by hysteresis [14] . Hysteresis is defined as a phenomenon where a higher level of PTH occurs to compensate for the same serum Ca level during a recovery phase from hypercalcemia. One report suggests that a drastic lowering of blood ionized Ca elicits an immediate large and transient release of PTH [15] . As a result, even when the serum level of Ca is high, intact-PTH can also be high especially when Ca level is steadily decreasing from a higher level. In the present case, when the Ca level was high enough to suppress intact-PTH level, serum Ca levels and intact-PTH were 13.5 mg/dl and 10 pg/ml, respectively, suggesting that the CaSR was intact. However, when intact-PTH was determined while serum Ca level was steadily decreasing with a block on calcium intake, intact-PTH still remained relatively high when compared to the serum Ca level. FHH is characterized by a low excretion of Ca into the urine despite a moderate hypercalcemia. Its Cca/Ccr ratio is typically less than 0.01 [16] . Interestingly, our patient's Cca/Ccr was decreased to an extreme low of 0.0045 [8] . FHH is regarded as an inherited disease in an autosomal dominant pattern. But, we found the serum Ca levels of her parents normal and the gene analysis of her CaSR revealed no mutation [9, 10, 17] . Furthermore, her urinary Ca excretion became normal (110 mg/day) after she discontinued Ca supplements.
The reason for her low excretion of Ca into the urine remains something to be investigated. Her overuse of diuretics and purgatives induced hypovolemia and elevated levels of PRA and PAC. Secondary aldosteronism usually causes hypokalemia and metabolic alkalosis. Even when she took potassium supplements, her serum level of potassium was at the lower limit and her HCO 3 -was at the upper limit, suggesting a state of metabolic alkalosis. It is known that alkalosis enhances tubular Ca reabsorption [18] , and that renal insufficiency reduces urinary Ca excretion [19] . We decided that the alkalosis caused by an overuse of diuretics and purgatives had reduced the urinary Ca excretion.
The findings of the present patient are very similar to milk-alkali syndrome [20] . Milk-alkali syndrome is caused by an excessive intake of calcium carbonate and milk products [21] . The syndrome leads to hypercalcemia, alkalosis, hyperphosphatemia, and renal failure. In contrast to classical milk-alkali syndrome [22, 23] , the present patient did not consume much milk products but her hyperphosphatemia developed because the Ca supplements were made of bovine bone, or calcium phosphate.
The total amount of vitamin D that the patient took daily from the amount contained in the calcium supplement and from other multivitamins was about 2,000 IU per day, which was within the recommended safe upper limit of vitamin D [1] . Vitamin D intoxication is characterized by high serum 25-OH D level, hypercalcemia, hypercalciuria, and hyperphosphatemia [24] , with variable serum 1,25-(OH) 2 D level [25, 26] . Since the hypercalcemia was resolved in a few weeks, vitamin D intoxication was unlikely [26] .
In conclusion, the reported patient's hypercalcemia was mainly caused by excessive intake of Ca supplements. Ca supplements are popular especially among women who are concerned about osteoporosis. Consumers are generally unaware of the tolerable upper intake level of Ca as no precaution is contained in the label to these products. The current case showed that excessive Ca intake could elicit deleterious effects on Ca metabolism and therefore the users of Ca supplements should be informed of these hazardous effects.
